Increased CD36 expression signals monocyte activation among patients with type 2 diabetes.
about
Differential expression of monocyte surface markers among TB patients with diabetes co-morbidityAdipose and muscle tissue profile of CD36 transcripts in obese subjects highlights the role of CD36 in fatty acid homeostasis and insulin resistance.Large multiethnic Candidate Gene Study for C-reactive protein levels: identification of a novel association at CD36 in African AmericansConvergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain (NOD) expression and signaling in monocytes from patients with type 2 diabetes.Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profileCD36 genetics and the metabolic complications of obesity.Activation of Peroxisome Proliferator-activated Receptor γ (PPARγ) and CD36 Protein Expression: THE DUAL PATHOPHYSIOLOGICAL ROLES OF PROGESTERONECD36 expression and lipid metabolism following an oral glucose challenge in South Asians.Plasma soluble CD36, carotid intima-media thickness and cognitive function in patients with type 2 diabetes.Substance P decreases fat storage and increases adipocytokine production in 3T3-L1 adipocytes.Predictors of Subclinical Inflammatory Obesity: Plasma Levels of Leptin, Very Low-Density Lipoprotein Cholesterol and CD14 Expression of CD16+ Monocytes.Maternal High-Fat and High-Salt Diets Have Differential Programming Effects on Metabolism in Adult Male Rat Offspring.Differential Expression of Human Peripheral Mononuclear Cells Phenotype Markers in Type 2 Diabetic Patients and Type 2 Diabetic Patients on MetforminHemodialysis-related changes in phenotypical features of monocytes
P2860
Q33639211-899E0E73-C8F6-47A0-B38F-7F6D457D3BF8Q33793807-3639EA3B-B127-45C2-AC33-C3A7540A8459Q33925367-50143E40-D6E2-4821-9C4E-41E4CB09A490Q34150760-B5D0F758-DFBA-49A3-98E2-1F402E270CAFQ34399408-76F92B84-06D4-46B9-ADA4-766797931C43Q35808557-62595E96-FA29-4040-804E-610032C19A5AQ37098920-FECCAAB1-6A80-4EC3-96CA-AB311A0D1D2CQ40297478-A07BD5BE-A719-4771-AB4D-99FA164C649FQ41549542-1483FADA-B959-42D2-B14C-488D49F70956Q42827675-B84AC490-BE33-4804-895E-164B0C7228FBQ47118534-498DB100-A040-4845-A246-32F64B286E24Q51732421-820C7AB8-A8FE-480A-A64E-02F0CBCD54C8Q57816632-E26077D4-805B-4F48-BA63-2A1EE337CE33Q58726638-9F4EAA79-C319-4A58-B171-E93141B76466
P2860
Increased CD36 expression signals monocyte activation among patients with type 2 diabetes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Increased CD36 expression sign ...... patients with type 2 diabetes.
@ast
Increased CD36 expression sign ...... patients with type 2 diabetes.
@en
Increased CD36 expression sign ...... patients with type 2 diabetes.
@nl
type
label
Increased CD36 expression sign ...... patients with type 2 diabetes.
@ast
Increased CD36 expression sign ...... patients with type 2 diabetes.
@en
Increased CD36 expression sign ...... patients with type 2 diabetes.
@nl
prefLabel
Increased CD36 expression sign ...... patients with type 2 diabetes.
@ast
Increased CD36 expression sign ...... patients with type 2 diabetes.
@en
Increased CD36 expression sign ...... patients with type 2 diabetes.
@nl
P2093
P2860
P356
P1433
P1476
Increased CD36 expression signals monocyte activation among patients with type 2 diabetes
@en
P2093
Antonios H Tzamaloukas
Edward J Bedrick
Glen H Murata
Karen S Servilla
Mark R Burge
Nada A Abumrad
Philip G Zager
Robert A Orlando
Ronald Schrader
Yijuan Sun
P2860
P304
P356
10.2337/DC10-0460
P407
P577
2010-06-14T00:00:00Z